Table 1 Differences according predominant to clinical presentation in Chronic Chagas Disease.
With VT (n=21) | Witout VT (n= 19) | p | |
|---|---|---|---|
Male sex, n(%) | 14 (66) | 8 (42) | 0.20 |
Age (years) | 58.5 ± 12.7 | 55.6 ± 13.4 | 0.48 |
EDLVD (mm) | 57 (54-76) | 63 (57-69) | 0.08 |
ESLVD (mm) | 46 (40-61) | 54 (48-64) | 0.14 |
LVEF(%) | 36.3 ±10.9 | 23.5 ± 10.6 | <0.001 |
LVEDV (ml ) | 165 (148-221) | 191 (132-230) | 0.16 |
LVESV (ml) | 99 (75-158) | 153 (82-193) | 0.02 |
Left Ventricular Mass (g) | 88 (85-114) | 106 (87-144) | 0.13 |
RVEF (%) | 43 (31-49) | 26 (18-45) | 0.03 |
RVEDV (ml) | 68 (58-96) | 100 (71-171) | 0.01 |
RVESV (ml) | 36 (32-67) | 68 (42-129) | 0.004 |
Ventricular Aneurism n(%) | 6 (28) | 3 (16) | 0.46 |
Thrombus | 1 (5) | 6 (32) | 0.04 |
Left Anterior Fascicular Block n(%) | 1 (4) | 3 (16) | 0.33 |
Segments with delayed enhacement | 8.9 ±3.0 | 9.3 ±3.6 | 0.69 |
Fibrosis grade (Cuantitative Delayed Enhacement) (gr) | 44.5 ±20.2 | 48.6 ± 30.5 | 0.62 |
Percentage of fibrosis (delayed enhacement %) | 43.8 ±13.0 | 46.4 ± 19.9 | 0.64 |